• Info
  • Insider Trading

Alan Fuhrman - Insider Trading & Ownership

Location
C/O Ambit Biosciences Corporation, 11080 Roselle Street, San Diego, CA
Summary
The estimated net worth of Alan Fuhrman is at least $320K dollars as of September 17, 2025. Alan Fuhrman is the Director of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $185K. Alan Fuhrman is the Chief Financial Officer of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $135K.
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Alan Fuhrman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Alan Fuhrman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ESPR Esperion Therapeutics, Inc. Director $185K May 23, 2024
TYRA Tyra Biosciences, Inc. Chief Financial Officer $135K Sep 15, 2025
SWTX SpringWorks Therapeutics, Inc. Director $0 Jul 1, 2025
CMPI Checkmate Pharmaceuticals, Inc. Director May 31, 2022

Insider Transactions Reported by Alan Fuhrman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.